In addition, many studies have focused on the treatment of cognitive impairment with diabetes drugs and have found that glucagon-like peptide-1 mimetic drugs are resistant to protease cleavage and can affect key pathophysiological pathways, thus preventing the development of DM and memory impairment [10]. The gene discussed is GCG; the disease is diabetes mellitus.